| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/16/2002 | WO2001070662A3 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 05/16/2002 | WO2001068144A3 Biodegradable immunomodulatory formulations and methods for use thereof |
| 05/16/2002 | WO2001068040A3 The use of plant extracts and sugars to protect keratinous tissue |
| 05/16/2002 | WO2001049654A3 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 05/16/2002 | WO2001046180A3 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 05/16/2002 | WO2001045664A3 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 05/16/2002 | WO2001045663A3 USE OF AROMATIC POLYCYCLIC COMPOUNDS AS ACTIVATORS OF PPARs-TYPE RECEPTORS IN A COSMETIC OR PHARMACEUTICAL COMPOSITION |
| 05/16/2002 | US20020058709 For therapy and prophylaxis of allergic disease of the eye, nose, skin, ear, gastrointestinal tract or lungs |
| 05/16/2002 | US20020058704 Multicomponent compositions containing chitosan and methods of preparing same |
| 05/16/2002 | US20020058700 Ion channel modulating agents |
| 05/16/2002 | US20020058692 Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents |
| 05/16/2002 | US20020058691 For use in therapy of pain, arthritis, fever |
| 05/16/2002 | US20020058687 For therapy and prohylaxis of inflammatory diseases including joint inflammation, Crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (COPD) including asthma, chronic bronchitis |
| 05/16/2002 | US20020058685 Hydantoin derivative compounds, pharmace utical compositions, and methods of using same |
| 05/16/2002 | US20020058682 Administering to a candidate subject in need of such treatment, a thus-effective amount of at least one inhibitor of at least one calcium channel for loosening/slackening and/or relaxing cutaneous and/or subcutaneous human skin |
| 05/16/2002 | US20020058681 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 05/16/2002 | US20020058680 Indolecarboxylic compounds for treating seborrhea and complications thereof |
| 05/16/2002 | US20020058678 For therapy of diseases or pathological conditions involving inflammation such as chronic inflammatory diseases |
| 05/16/2002 | US20020058653 Administering cyclic polyamine compound to elevate white blood cell (WBC) count |
| 05/16/2002 | US20020058635 Purine L-nucleosides, analogs and uses thereof |
| 05/16/2002 | US20020058631 Dipeptide derivatives |
| 05/16/2002 | US20020058630 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 05/16/2002 | US20020058619 Ligand for vascular endothelial growth factor receptor |
| 05/16/2002 | US20020058336 Controlling cell binding; obtain target cell, incubate with substrate, monitor cell binding |
| 05/16/2002 | US20020058284 Methods and compositions for treating macrophage-mediated diseases |
| 05/16/2002 | US20020058066 Outer layer portion containing cilostazol, a water-insoluble substance, such as ethyl cellulose, and a hydrophilic hydrogel forming substance, such as hydroxypropyl methyl cellulose. |
| 05/16/2002 | US20020058059 Antifungals inhibiting fungal ergosterol biosynthesis; synthetic, amphotheric phospholipid; particularly shampoos |
| 05/16/2002 | US20020058055 Oil-containing biliquid foam dispersed in a salt-containing aqueous phase having a pH of less than about 7, is gelled by a polymeric sulfonic acid, e.g., ammonium acrylamidopropanesulfonic acid-vinylformamide copolymer |
| 05/16/2002 | US20020058052 Amphipatic lipid containing a hydroxy and amide group; and of a surfactant in an aqueous medium; a washing-away type cosmetic composition comprising the dispersion |
| 05/16/2002 | US20020058051 Skin care compositions |
| 05/16/2002 | US20020058048 Contains a nonionic, amphoteric or cationic surfactant in an amount effective to eliminate or substantially ameliorate burning pain caused by capsaicin. |
| 05/16/2002 | US20020058036 Novel fibroblast growth factor and nucleic acids encoding same |
| 05/16/2002 | US20020058029 Anti-CD40L, anti-B7.1 (CD80), anti-B7.2(CD86), CD40 antibody or anti-CD4 antibody; both may be administered separately or in combination, and in any order. |
| 05/16/2002 | US20020058010 Foaming cosmetic cream for treating greasy skin and methods for using the same |
| 05/16/2002 | CA2428176A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 05/16/2002 | CA2428164A1 Method for the treatment of inflammation |
| 05/16/2002 | CA2428161A1 Substances causing differentiation |
| 05/16/2002 | CA2427757A1 Therapeutic uses for ip3 receptor-mediated calcium channel modulators |
| 05/16/2002 | CA2426037A1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | CA2425829A1 Proteases |
| 05/15/2002 | EP1205489A1 Polypeptide and nucleic acids encoding the same |
| 05/15/2002 | EP1205475A1 Flavonoid compounds for use against oxidative stress and UV radiation |
| 05/15/2002 | EP1205218A1 Topical antipsoriaticum comprising urea, a corticoid and a desinfectant |
| 05/15/2002 | EP1205191A1 Targeted modification of intracellular compounds |
| 05/15/2002 | EP1205184A1 Methylsilanol hydroxyproline aspartate-based composition |
| 05/15/2002 | EP1205178A2 Conjugate, method for its production and use thereof |
| 05/15/2002 | EP1205177A2 Conjugate, method for its production and use thereof |
| 05/15/2002 | EP1204754A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 05/15/2002 | EP1204744A1 Isolated peptide of the horny layer and use thereof |
| 05/15/2002 | EP1204681A2 Helical cytokine zalpha48 |
| 05/15/2002 | EP1204665A2 Chemokine receptor antagonists and methods of use therefor |
| 05/15/2002 | EP1204652A1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/15/2002 | EP1204649A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 05/15/2002 | EP1204646A1 1,4,5,6 -tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 05/15/2002 | EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 05/15/2002 | EP1204430A2 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 05/15/2002 | EP1204429A2 Sustained release formulation of a peptide |
| 05/15/2002 | EP1204419A1 Inhibitors of the lectin complement pathway (lcp) and their use |
| 05/15/2002 | EP1204404A1 Composition for topical administration comprising 5-methoxypsoralen |
| 05/15/2002 | EP1204321A2 Super-active porcine growth hormone releasing hormone analog |
| 05/15/2002 | EP1082028B1 Matthiola seed oil, mixtures containing it and use thereof |
| 05/15/2002 | EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines |
| 05/15/2002 | EP0930869B1 Deodorizing preparations |
| 05/15/2002 | EP0865278B1 Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat |
| 05/15/2002 | EP0854700B1 Use of bradykinin antagonists for stimulating or inducing hair growth and/or arresting hair loss |
| 05/15/2002 | EP0792163B1 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
| 05/15/2002 | EP0706513B1 Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 05/15/2002 | CN1349530A 1-(P-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds |
| 05/15/2002 | CN1349527A Substituted benzolactam compounds |
| 05/15/2002 | CN1349521A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 05/15/2002 | CN1349509A Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 05/15/2002 | CN1349504A Piperidine derivatives useful as CCR5 antagonists |
| 05/15/2002 | CN1349496A Caspase inhibitors and the use thereof |
| 05/15/2002 | CN1348811A Women's beautifying health care medicine |
| 05/15/2002 | CN1348807A Formula and prepn process of burn medicine oil |
| 05/15/2002 | CN1348806A Externally applied Chinese medicine ointment for treating malignant boil, furuncle, carbuncle and paronychia |
| 05/15/2002 | CN1348800A Ointment for treating chloasma and freckle |
| 05/15/2002 | CN1348799A Externally applied medicine for treating crab-louse disease |
| 05/15/2002 | CN1348793A Acne treating external-use medicine |
| 05/15/2002 | CN1348789A Medicine for treating burns and scalds |
| 05/15/2002 | CN1348779A Chloasma eliminating medicine |
| 05/15/2002 | CN1348771A Active animal protein liquid and its application |
| 05/15/2002 | CN1348765A Hand and foot fitting cream and its making process |
| 05/15/2002 | CN1348763A Medicine composite for preventing or treaitng diseases relating to IL-12 over growth |
| 05/15/2002 | CN1084744C N-substituted azaheterocyclic compounds |
| 05/15/2002 | CN1084740C Angiogensis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 05/15/2002 | CN1084627C Traditional Chinese medicine plaster for treating psoriasis |
| 05/14/2002 | US6388105 Antiproliferative agents; skin disorders; antiinflammatory agents |
| 05/14/2002 | US6388092 Antitumor agent |
| 05/14/2002 | US6387953 Inhibition of TNF-(α)-initiated neutrophil response |
| 05/14/2002 | US6387947 Mixture containing ferulic acid; topical applying |
| 05/14/2002 | US6387932 Somatostatin agonists |
| 05/14/2002 | US6387919 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/14/2002 | US6387918 A tricyclic compound (with oxy and nitrogen atoms in the ring); perticularly useful for treating or preventing psoriasis and other skin diseases |
| 05/14/2002 | US6387916 Administering to humans, animals |
| 05/14/2002 | US6387900 3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents |
| 05/14/2002 | US6387896 Bicyclic oxazolidinones as antibacterial agents |
| 05/14/2002 | US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 05/14/2002 | US6387891 Compounds with chelation affinity and selectivity for first transition series elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury |
| 05/14/2002 | US6387658 PCNA-associated cell cycle proteins, compositions and methods of use |